Company profile RGLS
After 39 days of this quarter the interest is at 18.0. Based on that we can calculate that during remaining 52 days it will total up to 42.0. Regulus Therapeutics stock expected interest is significantly lower compared to previous quarter (-52.3%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 33 | 99 200.0% QoQ | 91 -8.1% QoQ | 35 -61.5% QoQ |
| 2020 | 37 12.1% YoY 5.7% QoQ | 38 -61.6% YoY 2.7% QoQ | 31 -65.9% YoY -18.4% QoQ | 51 45.7% YoY 64.5% QoQ |
| 2021 | 107 189.2% YoY 109.8% QoQ | 49 28.9% YoY -54.2% QoQ | 93 200.0% YoY 89.8% QoQ | 65 27.5% YoY -30.1% QoQ |
| 2022 | 82 -23.4% YoY 26.2% QoQ | 61 24.5% YoY -25.6% QoQ | 100 7.5% YoY 63.9% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 56 -31.7% YoY inf% QoQ | 29 -52.5% YoY -48.2% QoQ | 0 -100.0% YoY -100.0% QoQ | 88 inf% YoY inf% QoQ |
| 2024 | 18 -67.9% YoY -79.5% QoQ | - | - | - |
The average 5 years interest of Regulus Therapeutics stock was 4.46 per week. The last year interest of Regulus Therapeutics stock compared to the last 5 years has changed by -30.04%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -37.1%.
There is not enough data for Regulus Therapeutics news to provide analysis
There is not enough data for Regulus Therapeutics news to provide correlation calculation
There is not enough data for Regulus Therapeutics news to provide analysis
There is not enough data for Regulus Therapeutics clinical trials to provide analysis
There is not enough data for Regulus Therapeutics clinical trials to provide correlation calculation
There is not enough data for Regulus Therapeutics clinical trials to provide analysis
There is not enough data for Regulus Therapeutics kidney disease to provide analysis
There is not enough data for Regulus Therapeutics kidney disease to provide correlation calculation
There is not enough data for Regulus Therapeutics kidney disease to provide analysis
There is not enough data for Regulus Therapeutics microRNAs to provide analysis
There is not enough data for Regulus Therapeutics microRNAs to provide correlation calculation
There is not enough data for Regulus Therapeutics microRNAs to provide analysis
Google Trends for Regulus Therapeutics biopharmaceuticals
Not enough data for reliable calculations!
There is not enough data for Regulus Therapeutics biopharmaceuticals to provide analysis
There is not enough data for Regulus Therapeutics biopharmaceuticals to provide correlation calculation
There is not enough data for Regulus Therapeutics biopharmaceuticals to provide analysis
There is not enough data for Regulus Therapeutics San Diego to provide analysis
There is not enough data for Regulus Therapeutics San Diego to provide correlation calculation
There is not enough data for Regulus Therapeutics San Diego to provide analysis
There is not enough data for Regulus Therapeutics company profile to provide analysis
There is not enough data for Regulus Therapeutics company profile to provide correlation calculation
There is not enough data for Regulus Therapeutics company profile to provide analysis
There is not enough data for Regulus Therapeutics pipeline to provide analysis
There is not enough data for Regulus Therapeutics pipeline to provide correlation calculation
There is not enough data for Regulus Therapeutics pipeline to provide analysis
There is not enough data for Regulus Therapeutics drug development to provide analysis
There is not enough data for Regulus Therapeutics drug development to provide correlation calculation
There is not enough data for Regulus Therapeutics drug development to provide analysis